Search & Analyze

Natco Pharma Ltd.

782.50−5.25 (−0.67%)

BSE · 30 Oct, 4:01 PM

: ₹15,350.14 Cr
: 13.41
: 27,665
: ₹801.15 - ₹780.00
: ₹1,216.20 - ₹774.00

Natco Pharma Ltd. (NATCOPHARM) share price closed at ₹782.50 on the BSE on Friday, October 30, 2026, down by 0.67% from its of ₹787.75. In that session NATCOPHARM reached a of 801.15 and of 780.00. The for the session was 786.45. The stands at 818.56 and is at 922.43. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹789.35

₹787.75

₹786.45

₹818.56

Price 4.41% below

₹922.43

Price 15.17% below

Key Fundamentals

: 15,350.14 Cr₹15.35 Thousand Crore
: 58.33
: 13.41
: 1.45
: 541.51
: 1,347.09 Cr₹1.35 Thousand Crore
: 0.63 %
Sector
Industry: Pharmaceuticals & Drugs
: 16.30
: 0.08

Industry Comparison

Ratio	Company	Sector
	13.41	44.77
	0.08	0.20
	1.45	4.61
	3.01	1.81
	0.63 %	0.11 %
Operating Margin	30.57 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Natco Pharma Ltd. NATCOPHARM	782.50	13.41	15,350.14	0.63	206.50	-57.01%	735.20	-44.68%	17.16

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	543.50	556.70	455.70	492.30	485.70	482.20	454.80	563.40	802.20	355.20	331.30	410.30	377.20	560.50	596.80	884.60	432.10	492.50	897.90	1,140.50	1,031.40	758.60	1,068.30	1,362.60	1,371.10	474.80	1,221.00	1,328.90	1,363.00	647.30	739.10	735.20
Expenses	323.00	348.30	307.40	301.00	351.40	353.50	326.50	392.30	525.80	272.70	255.10	300.50	306.70	458.70	615.40	489.30	336.80	386.60	558.80	612.50	573.40	490.50	571.00	557.80	566.80	436.00	672.90	757.90	783.80	488.60	611.50	548.70
	220.50	208.40	148.30	191.30	134.30	128.70	128.30	171.10	276.40	82.50	76.20	109.80	70.50	101.80	-18.60	395.30	95.30	105.90	339.10	528.00	458.00	268.10	497.30	804.80	804.30	38.80	548.10	571.00	579.20	158.70	127.60	186.50
	40.57%	37.43%	32.54%	38.86%	27.65%	26.69%	28.21%	30.37%	34.46%	23.23%	23.00%	26.76%	18.69%	18.16%	-3.12%	44.69%	22.06%	21.50%	37.77%	46.30%	44.41%	35.34%	46.55%	59.06%	58.66%	8.17%	44.89%	42.97%	42.49%	24.52%	17.26%	25.37%
	40.00	23.30	31.00	21.00	33.20	30.80	22.40	18.70	25.70	30.80	28.40	17.00	38.00	30.20	13.80	34.30	20.50	20.80	29.00	19.70	29.40	37.00	42.00	48.10	63.80	176.30	66.30	61.70	100.00	58.10	77.80	59.20
Interest	5.00	6.30	5.20	6.50	6.20	5.30	3.50	3.70	2.70	3.40	3.50	2.00	4.00	5.00	6.70	4.20	3.80	3.80	2.70	4.20	4.20	4.60	6.20	5.20	4.10	4.40	10.20	3.20	13.10	9.50	10.90	13.00
	20.20	20.70	21.70	22.00	21.90	25.40	30.50	28.00	28.70	29.80	30.40	33.80	34.70	36.00	38.10	39.60	41.70	41.50	41.00	43.50	43.60	44.20	55.50	44.10	45.80	47.00	98.30	57.60	52.40	46.20	50.40	47.10
	235.30	204.70	152.40	183.80	139.40	128.80	116.70	158.10	270.70	80.10	70.70	91.00	69.80	91.00	-49.60	385.80	70.30	81.40	324.40	500.00	439.60	256.30	477.60	803.60	818.20	163.70	505.90	571.90	613.70	172.00	179.80	269.90
	22.82%	22.18%	21.00%	22.31%	15.57%	18.94%	20.14%	22.77%	24.68%	20.85%	25.04%	17.58%	6.73%	11.65%	-1.81%	16.95%	19.20%	23.46%	14.98%	15.94%	16.06%	17.01%	19.12%	16.81%	17.32%	19.12%	19.75%	16.02%	15.61%	12.03%	-49.61%	23.49%
	182.50	159.50	120.80	143.20	119.00	104.50	94.10	122.80	202.40	62.70	53.00	75.00	65.10	80.40	-50.50	320.40	56.80	62.30	275.80	420.30	369.00	212.70	386.30	668.50	677.30	133.00	406.60	480.70	518.40	151.50	267.90	206.50
	9.89	8.67	6.62	7.87	6.54	5.74	5.17	6.75	11.12	3.45	2.90	4.11	3.57	4.41	-2.77	17.56	3.11	3.41	15.11	23.48	20.61	11.88	21.58	37.35	37.84	7.43	22.72	26.85	28.96	8.46	14.97	11.54

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	2,216.30	2,881.30	4,331.80	4,763.80	4,698.80
	1,944.80	2,707.10	3,998.80	4,429.50	4,078.30
EXPENDITURE :
Increase/Decrease in Stock	-16.80	-23.70	42.70	-12.50	-106.20
Raw Material Consumed	545.20	606.90	625.20	654.00	721.80
Power & Fuel Cost	76.40	81.90	88.90	93.10	96.90
Employee Cost	444.80	486.70	525.00	594.50	687.20
Other Manufacturing Expenses	353.60	279.60	368.40	374.80	560.50
General and Administration Expenses	152.80	208.80	313.00	304.00	376.20
Selling and Distribution Expenses	43.70	96.10	153.00	136.40	173.20
Miscellaneous Expenses	81.60	59.10	131.20	91.40	132.20
	1,681.30	1,795.40	2,247.40	2,235.70	2,641.80
Operating Profit (Excl OI)	263.50	911.70	1,751.40	2,193.80	1,436.50
	99.00	128.50	128.10	356.70	297.60
	362.50	1,040.20	1,879.50	2,550.50	1,734.10
Interest	17.70	14.50	19.20	23.90	36.70
PBDT	344.80	1,025.70	1,860.30	2,526.60	1,697.40
	142.60	163.80	186.80	235.20	206.60
Profit Before Taxation & Exceptional Items	202.20	861.90	1,673.50	2,291.40	1,490.80
	202.20	861.90	1,673.50	2,291.40	1,490.80
Provision for Tax	32.20	146.60	285.20	408.00	118.90
	170.00	715.30	1,388.30	1,883.40	1,371.90
Extra items	0.00	0.00	0.00	0.00	0.00
Minority Interest				2.00
Share of Associate					46.60
Consolidated Net Profit	170.00	715.30	1,388.30	1,885.40	1,418.50
Profit Balance B/F	2,568.20	2,666.60	3,292.30	4,465.70	6,246.60
Appropriations	2,738.20	3,381.90	4,680.60	6,351.10	7,665.10
Equity Dividend %	225.00%	275.00%	475.00%	300.00%	250.00%
	9.32	39.19	77.56	105.33	79.25
Adjusted EPS	9.24	38.88	76.93	104.48	78.61

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	36.50	36.50	35.80	35.80	35.80
Share Warrants & Outstandings	3.40
Total Reserves	4,223.70	4,837.30	5,817.30	7,571.20	9,185.30
Reserve excluding Revaluation Reserve	4,223.70	4,837.30	5,817.30	7,571.20	9,185.30
Revaluation reserve			0.00
	4,263.60	4,873.80	5,853.10	7,607.00	9,221.10
Minority Interest				5.30
Secured Loans					100.00
Deferred Tax Assets / Liabilities	30.10	12.40	-19.20	-49.90	-232.40
Other Long Term Liabilities	9.30	2.80	9.30	9.20	9.70
Long Term Provisions	95.70	85.30	70.90	65.60	61.80
Total Non-Current Liabilities	135.10	100.50	61.00	24.90	-60.90
Trade Payables	161.80	263.80	235.50	274.90	409.30
Other Current Liabilities	126.70	227.30	238.90	238.60	614.50
Short Term Borrowings	404.00	165.00	363.20	273.10	306.40
Short Term Provisions	17.90	27.00	135.20	156.90	350.70
Total Current Liabilities	710.40	683.10	972.80	943.50	1,680.90
Total Liabilities	5,109.10	5,657.40	6,886.90	8,580.70	10,841.10
Gross Block	3,126.90	3,375.10	3,603.20	4,015.20	4,255.70
Less: Accumulated Depreciation	815.10	948.20	1,112.40	1,267.20	1,403.00
Less: Impairment of Assets				50.00	50.00
	2,311.80	2,426.90	2,490.80	2,698.00	2,802.70
	129.50	64.30	137.30	225.40	293.70
Non Current Investments	104.40	87.30	95.90	152.80	2,548.90
Long Term Investment	104.40	87.30	95.90	152.80	2,548.90
Long Term Loans & Advances	72.00	78.30	112.70	73.80	100.80
Other Non Current Assets	4.70	0.30	26.70	160.70	42.70
Total Non-Current Assets	2,622.40	2,657.10	2,863.40	3,310.70	5,788.80
Currents Investments	203.70	305.00	443.50	320.80	578.20
Inventories	762.00	742.90	700.50	765.80	908.50
Sundry Debtors	620.60	856.10	1,188.90	1,246.60	881.20
Cash and Bank	206.10	546.30	952.90	2,176.00	1,550.90
Other Current Assets	88.10	64.40	99.50	135.10	102.40
Short Term Loans and Advances	606.20	485.60	638.20	625.70	1,031.10
Total Current Assets	2,486.70	3,000.30	4,023.50	5,270.00	5,052.30
Net Current Assets (Including Current Investments)	1,776.30	2,317.20	3,050.70	4,326.50	3,371.40
Total Assets	5,109.10	5,657.40	6,886.90	8,580.70	10,841.10
	8.00	14.60	0.40	3.00	3.00
Total Debt	404.00	165.00	363.20	273.10	706.40
	233.44	267.06	326.99	424.97	515.15
Adjusted Book Value	233.44	267.06	326.99	424.97	515.15

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	202.20	861.90	1,673.50	2,291.40	1,490.80
Adjustment	123.90	102.00	133.80	-22.30	29.70
Changes In working Capital	-231.40	62.70	-309.40	-199.70	645.50
Cash Flow after changes in Working Capital	94.70	1,026.60	1,497.90	2,069.40	2,166.00
Cash Flow from Operating Activities	46.50	849.10	1,211.60	1,696.80	1,768.30
Cash Flow from Investing Activities	-5.30	-477.10	-1,032.70	-1,414.50	-2,081.70
Cash Flow from Financing Activitie	34.80	-363.00	-246.90	-210.70	297.50
Net Cash Inflow / Outflow	76.00	9.00	-68.00	71.60	-15.90
Opening Cash & Cash Equivalents	25.80	111.10	131.90	70.40	120.00
Effect of Foreign Exchange Fluctuations	9.30	11.80	6.50	-22.00	94.80
Closing Cash & Cash Equivalent	111.10	131.90	70.40	120.00	198.90

Ratios

Valuation

13.41

1.45

10.77

4.41

58.33

541.51

Profitability

16.30

17.16

14.13

30.57

29.20

Leverage & Liquidity

0.08

3.01

41.62

Returns

0.63

0.48

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	49.71	49.62	49.62	49.56	49.56	49.48	49.48	49.42	49.42	49.39
	25.31	24.26	23.51	22.97	21.16	19.96	20.54	22.82	22.60	22.15
	24.97	26.12	26.88	27.46	29.28	30.56	29.97	27.76	27.98	28.46
	50.29	50.38	50.38	50.44	50.44	50.52	50.52	50.58	50.58	50.61
No. of Shareholders	2,51,485	3,02,944	3,45,332	4,05,222	4,29,434	4,19,699	4,24,167	4,10,970	4,03,166	4,04,135

Mutual Funds Invested(84)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 20 active funds hold 1.58% in Natco Pharma Ltd., contributing to ₹256 Cr of holdings

Fund				As of
TA Tata Small Cap Fund - Growth - Direct PlanSmall cap Fund	68.57	0.52	8,28,616	Sep '26
TA Tata Value Fund - Growth - Direct PlanEquity - Value Fund	57.93	0.70	7,00,001	Sep '26
SU Sundaram Small Cap Fund - Growth - Direct PlanSmall cap Fund	45.65	1.11	5,51,707	Sep '26
TA Tata India Pharma & Healthcare Fund - Growth - Direct PlanPharma & Health Care	22.77	1.51	2,75,137	Sep '26
ID Bandhan Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	22.76	0.77	2,75,000	Sep '26
QU Quant Healthcare Fund - Growth - Direct PlanPharma & Health Care	12.78	3.01	1,54,500	Sep '26
NI Nippon India Nifty Smallcap 250 Index Fund - Growth - Direct PlanIndex Funds - Other	11.50	0.33	1,38,942	Sep '26
AB Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct PlanPharma & Health Care	9.93	0.92	1,20,000	Sep '26
HD HDFC NIFTY Smallcap 250 ETFIndex	9.02	0.33	1,09,023	Sep '26
AX Axis Nifty Smallcap 50 Index Fund - Growth - Direct PlanIndex Funds - Other	6.79	0.87	82,108	Sep '26

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-10-29	Board Meeting	Quarterly Results & Interim Dividend
2026-09-22	Board Meeting	Fund Raising
2026-09-22	Rights Announcement	Right Issue of Equity Shares & Inter alia, to consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue.	2026-10-01	2026-10-01

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-10-29	RAJEEV NANNAPANENI	Allotment	Buy	58,666
2026-10-29	SAU FAMILY TRUST	Allotment	Buy	161
2026-10-29	NEERUKONDA SRINIVAS	Allotment	Buy	240
2026-10-29	PRAVEEN CHOWDARY MYNENI	Allotment	Buy	899
2026-10-29	RAJESH CHEBIYAM	Allotment	Buy	1,000
2026-10-29	SANDEEP KUMAR	Allotment	Buy	22
2026-10-29	LINGARAO DONTHINENI	Allotment	Buy	5,157
2026-10-29	MANTRI PRABHAKAR RAO	Allotment	Buy	100
2026-10-29	MAHESH KOKKULA	Allotment	Buy	29
2026-10-29	NITIN JAIN HUF	Allotment	Buy	3,000
2026-10-29	NATCO AQUA LTD	Allotment	Buy	1,523
2026-10-29	NEELIMA SITA NANNAPANENI	Allotment	Buy	255,387
2026-10-29	NATSOFT INFORMATION SYSTEMS PVT LTD	Allotment	Buy	240,000
2026-10-29	RAO SREENIVASA PARUPALLI	Allotment	Buy	492
2026-10-29	GNANADEVA CHALAPATHY GUDIPATI	Allotment	Buy	676
2026-10-29	G VASAN	Allotment	Buy	300
2026-10-29	LAKSHMI NARAYANA ARE	Allotment	Buy	4,500
2026-10-29	KANTAMANI RATNA KUMAR	Allotment	Buy	4,761
2026-10-29	CHEKURI VENKAT RAMESH	Allotment	Buy	114
2026-10-29	SIVARAMAKRISHNA PRASAD POTLURI	Allotment	Buy	4,000

Sector Overview

HealthcarePharmaceuticals & Drugs

Natco Pharma Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

Chekuri Venkat Ramesh

Company Secretary & Compliance Officer

—

V C Nannapaneni

Chairman & Managing Director

₹7.60 Cr

Mar '26

Rajeev Nannapaneni

Vice Chairman & CEO

₹7.39 Cr

Mar '26

ADM Chavali